Lange A P
Acta Obstet Gynecol Scand Suppl. 1983;113:117-24. doi: 10.3109/00016348309155212.
Within the last few years intra-amniotic (i.a.) instillation of prostaglandin F2 alpha (PGF2 alpha) has become the predominant method of second-trimester abortion in Denmark. The method is employed by nearly all the gynecological departments, where approximately 500 such procedures are carried out annually. Our own investigations have demonstrated that it is necessary to be somewhat restrictive in the administration of supplementary intravenous infusion of oxytocin. It is pointed out, illustrated by four case histories, that there is a potential risk of greater or smaller quantities of i.a. PGF2 alpha accidentally passing during the procedure to the circulation of the patient. This may result in circulatory collapse, among other things, possibly as a result of acute pulmonary hypertension. A number of safety measures are suggested to minimize this risk and to ensure effective treatment should such complications occur.
在过去几年中,羊膜腔内注入前列腺素F2α(PGF2α)已成为丹麦孕中期堕胎的主要方法。几乎所有妇科科室都采用这种方法,每年大约进行500例此类手术。我们自己的调查表明,在补充静脉滴注催产素时必须有所限制。通过四个病例史指出,在手术过程中,有或多或少的羊膜腔内PGF2α意外进入患者循环的潜在风险。这可能导致循环衰竭等情况,可能是由于急性肺动脉高压所致。建议采取一些安全措施以尽量降低这种风险,并确保在发生此类并发症时能进行有效治疗。